Emanual Michael Maverakis MD

Associate Professor, University of California Davis

3301 C StSte 100Sacramento, CA 95816
Phone+1 916-734-6371
Fax+1 916-734-6793

Dr. Maverakis is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Maverakis' full profile Already have an account?

Clinical Expertise

Immunology, Tumor immunotherapy, Tumor immunology, Autoimmune diseases, Dermatology, Melanoma

Education & Training

University of California Davis HealthResidency, Dermatology, 2004 - 2007
Beth Israel Deaconess Medical CenterInternship, Internal Medicine, 2003 - 2004
Harvard Medical SchoolClass of 2003

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

CA State Medical License 2005 - 2027
American Board of Dermatology Dermatology
American Board of Preventive Medicine Clinical Informatics

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016
PECASE President Barack Obama, 2011

Clinical Trials

Characterization of the Melanoma-Specific Immune Response
UNKNOWN
T Cell Repertoire Analysis of Immune Mediated Skin Diseases
COMPLETED
Alternation in the Human Microbiome With Commonly Used Topical Medications Start of enrollment: 2013 Jan 28
RECRUITING
PHASE1

Publications & Presentations

PubMed

Observational Study Profiling the Immune Microenvironment of Pregnancy-associated Melanoma.
Maha Kazmi, Marin P Melloy, Sabine Abukhadra, Jessica R Terrell, Qian Li
The American Journal of Dermatopathology. 2026-09-01
CD19 CAR T-cell therapy is feasible for patients with pemphigus vulgaris treated without lymphodepletion in the RESET-PV trial.
Daniel Nunez, Jason Stadanlick, Thomas Furmanak, Jessica Goldenberg, Gaurav S Choudhary
Blood. 2026-07-30
Single-cell transcriptome reveals keratinocyte subclusters contributing to altered differentiation and inflammatory responses in atopic dermatitis.
Tingting Qin, Rachael Bogle, Rundong Jiang, Mrinal K Sarkar, Yuli Cai
Nature Communications. 2026-07-14

Journal Articles

Paradoxical Effects of Obesity on T Cell Function During Tumor Progression and PD-1 Checkpoint Blockade
R Rivkah Isseroff, Emanual Maverakis, Robert J Canter, Kurt A Schalper, Karen Kelly, Bruce R Blazar, Catherine T Le, Dan L Longo, Arta M Monjazeb, Sami Ibrahimi, Nature

Press Mentions

KHN Morning BriefingJune 1st, 2022
National Psoriasis Foundation Awards $2.8 Million in Research Grants and FellowshipsJuly 12th, 2019
Telehealth Models Just as Effective as in-Person Care When Treating Psoriasis PatientsOctober 8th, 2018

Grant Support

Mentoring Translational Scientists in Clinical Trial Immune MonitoringUNIVERSITY OF CALIFORNIA AT DAVIS2021–2026
HIV Reservoir and Gene Modified Cell Dynamics Following Autologous Stem Cell TransplantationUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2023–2025
Characterization Of Pathogenic T Cells In Alopecia AreataNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2010–2012
Investigation And Development Of New Therapeutic Avenues For SclerodermaOffice Of The Director, National Institutes Of Health2011
Gc399tr An Inhibitor Of AutoimmunityNational Institute Of Allergy And Infectious Diseases2008–2010